Congress locks in NIH funding, blocking executive freeze power
H.R. 2855 — Protecting Medical Research Funding Act · Filed by Timothy Kennedy (D-NY) · 1 cosponsor · Introduced Apr 10, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill prevents the executive branch from freezing, redirecting, or reallocating NIH funding without explicit new legislation. It requires the HHS Secretary to certify annually that NIH funds are being spent as Congress appropriated them, blocking the President from using executive power to withhold or reprogram medical research money.
Why we flagged it
The bill's core function is to shield congressionally appropriated NIH funds from executive impoundment or reprogramming. It is a procedural/governance measure that enforces the separation of powers by preventing the President from unilaterally freezing or redirecting money Congress has already allocated.
What the text implies
- The bill may constrain future executive flexibility in responding to fiscal emergencies or policy shifts, though it preserves Congress's ability to authorize transfers via new legislation.
- The annual certification requirement creates a compliance record that could expose executive non-compliance to congressional oversight and potential legal challenge.
The full analysis lists 3 implications of this text.
Who stands to gain
biomedical research institutions; pharmaceutical and medical device companies (indirect, via research pipeline); academic medical centers and universities